Drug Type Small molecule drug |
Synonyms 2000 (3H Pharmaceuticals), 3HP 2827, 3HP-2827 + [1] |
Target |
Action antagonists |
Mechanism FGFR2 antagonists(Fibroblast growth factor receptor 2 antagonists) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
RegulationFast Track (United States), Orphan Drug (United States) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 2 | China | 17 Jun 2024 | |
FGFR2 Mutation Solid Tumors | Phase 2 | China | 17 Jun 2024 | |
FGFR2 Mutant Neoplasms | Phase 2 | China | 06 Jun 2024 |